Publication | Closed Access

A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment

Surgical OncologyGynecological SurgeryPhase Ii TrialMedicineIntraperitoneal CisplatinGynecologyConsolidation TherapySurgeryCancer TreatmentOncologyGynecology OncologyOvarian Cancer